Clinical trial Recruiting at 1 site Interventional Ages 16 and up

Surgery With Prehabilitation, Direct Surgery, or Rehab for Hip Impingement

Official title: Comparison of Outcomes of Surgery Combined With Prehabilitation, Direct Surgery, and Rehabilitation Alone in Patients With Femoroacetabular Impingement

Run by Peking University Third Hospital · NCT07894471 · Data updated 2026-11-12

This study tests three approaches for femoroacetabular impingement to see which helps hip pain and function best: surgery with prehab, surgery without prehab, or rehabilitation alone.

More Femoroacetabular Impingement Syndrome trials

Quick facts

Study typeInterventional
Ages16 Years and up
SexAll
Enrollment360 (estimated)
SponsorPeking University Third Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedJuly 6, 2026
Main results expectedJuly 2036
Study endsJuly 2036
Registry record updatedOctober 26, 2026
Trial IDNCT07894471 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 16 or older with imaging-confirmed Cam- or Pincer-type FAI who are considered likely to benefit from hip arthroscopy or a rehabilitation program.

Probably not a fit

Patients with advanced hip osteoarthritis or prior hip surgeries, or those not expected to benefit from either surgery or rehabilitation, may derive little or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study compares three treatment pathways for femoroacetabular impingement. Participants are assigned to: hip arthroscopic surgery with a prehabilitation program, direct hip arthroscopic surgery without prehabilitation, or standardized rehabilitation alone. Outcomes include pain and hip function over follow-up to determine which approach yields the best results. The trial addresses whether adding prehabilitation to surgery or using rehabilitation alone offers advantages for patients with Cam- or Pincer-type impingement.

Why it matters

Potential benefit: If successful, the trial could identify the most effective sequence of therapy to relieve pain and improve hip function in FAI.

How similar studies have gone: Prior research has explored rehabilitation and arthroscopic surgery for FAI, but direct comparisons among these three strategies remain relatively limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Presence of hip pain with imaging evidence of Cam- or Pincer-type femoroacetabular impingement morphology;
2. Age ≥ 16 years;
3. Able to provide written informed consent;
4. Physician judgment that the patient is likely to benefit from hip arthroscopic surgery or a rehabilitation program.

Exclusion Criteria:

1. Concomitant hip osteoarthritis (Tönnis grade \> 1, or joint space \< 2 mm on the anteroposterior pelvic radiograph);
2. History of prior hip pathology, including Legg-Calvé-Perthes disease, slipped capital femoral epiphysis, or avascular necrosis of the femoral head;
3. History of prior hip trauma, including acetabular fracture, hip dislocation, or femoral neck fracture;
4. Previous hip surgery (open or arthroscopic);
5. Completion of a rehabilitation program specifically for FAIS within the past 12 months;
6. Hip dysplasia (lateral center-edge angle \< 20°).

Where it's running

  • Peking University Third Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.